IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CRVS

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Cash & Equivalents18.9140.104.582.8714.695.008.744.6814.847.4612.6220.117.669.6524.5928.4831.4613.1672.3058.92
Accounts Receivable0.010.040.040.030.090.080.080.070.040.030.030.010.59--------------
Total Current Assets220.97239.9558.2166.9475.7845.4954.4142.9248.2622.8527.9633.0937.9135.5551.2758.8964.3743.6678.7669.12
Property, Plant & Equipment0.830.280.220.220.250.170.150.170.190.210.240.260.290.330.450.530.360.350.540.65
Total Non-current Assets*18.3113.2512.9113.5313.6813.9514.5015.8916.3017.2317.6018.8520.1322.6529.0833.6636.9224.5840.5740.27
Total Assets239.27253.2071.1280.4789.4659.4468.9158.8264.5640.0845.5551.9458.0458.2080.3592.54101.2968.24119.32109.39
Accounts Payable4.054.702.491.973.141.312.581.871.211.611.531.402.101.414.232.652.191.982.332.87
Total Current Liabilities13.6712.119.388.078.519.2835.4046.4113.346.726.877.307.868.2913.9810.169.2710.7511.3112.36
Total Non-current Liabilities*0.270.410.530.630.730.830.940.000.000.000.000.350.701.041.692.002.301.372.870.63
Total Liabilities13.9512.529.918.719.2310.1136.3446.4113.346.726.877.658.569.3315.6712.1611.5712.1314.1812.99
Retained Earnings(443.94)(425.98)(412.29)(399.97)(389.81)(381.82)(397.01)(384.90)(344.68)(340.42)(334.72)(328.06)(322.06)(315.56)(297.87)(283.04)(274.68)(307.69)(257.14)(246.47)
Total Stockholder Equity225.33240.6861.2171.7780.2349.3332.5712.4151.2333.3638.6844.2949.4848.8764.6880.3989.7256.12105.1596.40
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Research & Development15.9611.189.948.457.877.455.975.224.114.084.003.973.974.5910.374.925.104.086.999.11
Selling, General & Admin3.333.702.282.122.392.472.132.031.822.181.651.601.651.982.112.092.311.592.062.18
Total Operating Expenses19.3014.8812.2210.5710.269.928.117.265.946.255.655.565.626.5712.477.017.415.679.0511.29
Operating Income(19.30)(14.88)(12.22)(10.57)(10.26)(9.92)(8.10)(7.25)(5.93)(6.25)(5.65)(5.56)(5.62)(6.57)(12.47)(7.01)(7.41)(5.67)(9.05)(11.29)
Pretax Income(17.25)(13.09)(11.61)(9.83)(7.61)15.73(9.94)(39.53)(3.68)(5.94)(10.53)------------------
Tax Provision0.000.00--------0.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Net Income(17.96)(13.69)(12.32)(10.16)(8.00)15.19(12.11)(40.22)(4.26)(5.70)(6.65)(6.00)(6.50)(7.87)(14.83)(8.36)(8.30)(9.82)(10.67)(11.75)
Basic EPS(0.19)(0.15)(0.18)(0.12)(0.10)0.21(0.23)(0.60)(0.07)(0.12)(0.13)(0.12)(0.14)(0.17)(0.32)(0.18)(0.18)(0.21)----
Diluted EPS(0.19)(0.15)(0.18)(0.12)(0.10)(0.13)(0.23)(0.60)(0.07)(0.12)(0.13)(0.12)(0.14)(0.17)(0.26)(0.18)(0.18)(0.27)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(15.40)(10.37)(9.19)(9.57)(5.78)(8.26)(8.46)(6.32)(5.48)(5.16)(5.17)(5.43)(5.22)(8.11)(6.93)(6.12)(6.42)(6.86)(8.43)(12.65)
Capital Expenditures0.580.090.030.000.110.04--------0.000.000.000.030.270.00--------
Free Cash Flow*(15.98)(10.46)(9.22)(9.57)(5.89)(8.30)--------(5.17)(5.43)(5.22)(8.14)(7.19)(6.13)--------
Investing Cash Flow(5.96)(144.85)10.88(2.62)(20.30)4.24(6.08)(3.89)(17.50)(0.01)(2.32)17.55(4.29)4.603.043.14(25.57)(2.00)3.4715.24
Financing Cash Flow0.17190.750.020.3635.770.2818.610.0530.37--0.000.347.520.00------0.0218.3311.22
← Scroll for more columns →

* Derived from reported values